Exelixis (EXEL) Shareholder's Equity Growth (3y) (2013 - 2026)
Exelixis (EXEL) Shareholder's Equity Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Exelixis |
13.37 Bn |
12.59 Bn |
590.86 Mn |
| Date | Value |
|---|
| Apr 3, 2026 |
-8.84% |
| Jan 2, 2026 |
-4.59% |
| Oct 3, 2025 |
-4.64% |
| Jul 4, 2025 |
-5.26% |
| Apr 4, 2025 |
-2.42% |
| Jan 3, 2025 |
0.50% |
| Sep 27, 2024 |
2.51% |
| Jun 28, 2024 |
1.24% |
| Mar 29, 2024 |
3.65% |
| Dec 29, 2023 |
6.41% |
| Sep 29, 2023 |
8.22% |
| Jun 30, 2023 |
11.30% |
| Mar 31, 2023 |
13.50% |
| Dec 30, 2022 |
13.86% |
| Sep 30, 2022 |
15.82% |
| Jul 1, 2022 |
17.12% |
| Apr 1, 2022 |
18.31% |
| Dec 31, 2021 |
19.75% |
| Oct 1, 2021 |
32.12% |
| Jul 2, 2021 |
38.13% |
